Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
65.80
+1.18 (+1.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
March 29, 2024
Both stocks are pretty risky, but one of them more so than the other.
Via
The Motley Fool
Why Viking Therapeutics Stock Was Rocketing Higher This Week
March 29, 2024
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.
Via
The Motley Fool
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
March 28, 2024
The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break.
Via
Investor's Business Daily
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
March 28, 2024
This high-flying biotech stock has captured investors' attention for all the right reasons.
Via
The Motley Fool
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
Viking Therapeutics: Buy, Sell, or Hold?
March 26, 2024
It has a promising candidate and plenty of cash in hand.
Via
The Motley Fool
2 Incredible Growth Stocks to Buy Right Now
March 20, 2024
These two biotech stocks could be big winners in the years ahead.
Via
The Motley Fool
Viking Therapeutics Unusual Options Activity For March 19
March 19, 2024
Via
Benzinga
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
March 26, 2024
Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in New York. The S&P 500 saw a modest uptick of 0.3% for the day, with the Dow...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...
Via
Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
March 19, 2024
Don't bet on this pitfall happening, but know that it's a possibility.
Via
The Motley Fool
Where Will Viking Therapeutics Be in 5 Years?
March 17, 2024
Expectations for the stock are high, and it could well deliver.
Via
The Motley Fool
DNUT Stock Soars 29% as McDonald’s Deal Supercharges Krispy Kreme
March 26, 2024
Krispy Kreme stock is rising higher on Tuesday with heavy trading of DNUT shares alongside a new collaboration agreement with McDonald’s.
Via
InvestorPlace
Why Viking Therapeutics Stock Is Skyrocketing Today
March 26, 2024
The high-flying biotech company delivered more good news about a weight loss drug candidate.
Via
The Motley Fool
MSTR Stock Alert: MicroStrategy Releases New AI Bot
March 26, 2024
MicroStrategy stock is up on Tuesday as investors in MSTR shares react to news of a new AI bot released by the data analytics company.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
March 26, 2024
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.
Via
InvestorPlace
Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
March 26, 2024
Explore Viking Therapeutics' Phase 1 MAD trial results for oral VK2735, a promising treatment for metabolic disorders like obesity. Dose-dependent reductions in body weight, encouraging...
Via
Benzinga
Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
March 26, 2024
People lost more weight than the company expected over a 28-day study.
Via
Investor's Business Daily
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
March 26, 2024
All three of these high-flying stocks could have more room to run.
Via
The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
March 26, 2024
Find out why investment banks up and down Wall Street have big expectations for these stocks.
Via
The Motley Fool
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Via
InvestorPlace
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
March 25, 2024
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
Via
The Motley Fool
Is Viking Therapeutics Stock a Millionaire Maker?
March 24, 2024
Viking Therapeutics has become one of the hottest healthcare stocks of 2024.
Via
The Motley Fool
Where Will Viking Therapeutics Stock Be in 10 Years?
March 23, 2024
Viking's future appears to be very promising, but market dynamics can change.
Via
The Motley Fool
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
March 22, 2024
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Via
The Motley Fool
Could Viking Therapeutics Become the Next Eli Lilly?
March 22, 2024
Viking shares have skyrocketed on its recent good news.
Via
The Motley Fool
Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
March 21, 2024
The company might enter the hottest segment in the pharmaceutical sphere before long.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.